XP analyst estimates
XP (XP) analyst ratings, the average price target and its range, and every firm's latest call.
- 5 firms rate XP: 4 buy, 1 hold, 0 sell.
- The average price target is $25.40 from None analysts, from $15.00 to $37.00.
XP analyst ratings and price targets
| Date | Firm | Call | Target |
|---|---|---|---|
| Oct 29, 2026 | Morgan Stanley | Morgan Stanley Downgrades XP Inc. (XP) to Equalweight | $19.00 |
| Oct 29, 2026 | Morgan Stanley | XP Inc. downgraded to Equal Weight from Overweight at Morgan Stanley | $23.00 |
| Oct 29, 2026 | Banco Santander | XP Inc. downgraded to Neutral from Outperform at Grupo Santander | $19.00 |
| Oct 27, 2026 | Citigroup | XP Inc. downgraded to Neutral from Buy at Citi | $15.00 |
| Oct 20, 2026 | Bank of America Securities | XP Inc. price target raised to $33 from $21 at BofA | $33.00 |
| Oct 8, 2026 | UBS | XP Inc. price target raised to $37 from $25 at UBS | $37.00 |
| Jan 19, 2026 | Jefferies | XP Inc. initiated with a Buy at Jefferies | $22.00 |
| Dec 16, 2025 | UBS | XP Inc. price target raised to $25 from $23 at UBS | $25.00 |
| Oct 16, 2025 | UBS | XP Inc. price target lowered to $23 from $24 at UBS | $23.00 |
| Jul 11, 2024 | UBS | XP Inc. downgraded to Neutral from Buy at UBS | $21.00 |
| Jul 2, 2024 | Bradesco | XP Inc. assumed with Neutral from Outperform at Bradesco BBI | $19.00 |
| Apr 30, 2024 | Goldman Sachs | Goldman Sachs Downgrades XP Inc. (XP) to Neutral, 'Waiting for (much) lower rates' | $23.00 |
| Apr 22, 2024 | Morgan Stanley | XP Inc. downgraded to Equal Weight from Overweight at Morgan Stanley | $24.00 |
| Jan 24, 2024 | Bradesco | Bradesco BBI Upgrades XP Inc. (XP) to Outperform | $32.00 |
| Jul 20, 2023 | Credit Suisse | Credit Suisse Upgrades XP Inc. (XP) to Neutral | $26.00 |